AIRLINK 196.38 Increased By ▲ 4.54 (2.37%)
BOP 10.11 Increased By ▲ 0.24 (2.43%)
CNERGY 7.75 Increased By ▲ 0.08 (1.04%)
FCCL 38.10 Increased By ▲ 0.24 (0.63%)
FFL 15.74 Decreased By ▼ -0.02 (-0.13%)
FLYNG 24.54 Decreased By ▼ -0.77 (-3.04%)
HUBC 130.38 Increased By ▲ 0.21 (0.16%)
HUMNL 13.73 Increased By ▲ 0.14 (1.03%)
KEL 4.60 Decreased By ▼ -0.07 (-1.5%)
KOSM 6.19 Decreased By ▼ -0.02 (-0.32%)
MLCF 44.85 Increased By ▲ 0.56 (1.26%)
OGDC 206.51 Decreased By ▼ -0.36 (-0.17%)
PACE 6.58 Increased By ▲ 0.02 (0.3%)
PAEL 39.77 Decreased By ▼ -0.78 (-1.92%)
PIAHCLA 17.20 Decreased By ▼ -0.39 (-2.22%)
PIBTL 7.99 Decreased By ▼ -0.08 (-0.99%)
POWER 9.20 Decreased By ▼ -0.04 (-0.43%)
PPL 178.91 Increased By ▲ 0.35 (0.2%)
PRL 38.93 Decreased By ▼ -0.15 (-0.38%)
PTC 24.31 Increased By ▲ 0.17 (0.7%)
SEARL 109.27 Increased By ▲ 1.42 (1.32%)
SILK 1.00 Increased By ▲ 0.03 (3.09%)
SSGC 37.75 Decreased By ▼ -1.36 (-3.48%)
SYM 18.83 Decreased By ▼ -0.29 (-1.52%)
TELE 8.53 Decreased By ▼ -0.07 (-0.81%)
TPLP 12.14 Decreased By ▼ -0.23 (-1.86%)
TRG 64.76 Decreased By ▼ -1.25 (-1.89%)
WAVESAPP 12.11 Decreased By ▼ -0.67 (-5.24%)
WTL 1.64 Decreased By ▼ -0.06 (-3.53%)
YOUW 3.87 Decreased By ▼ -0.08 (-2.03%)
BR100 12,000 Increased By 69.2 (0.58%)
BR30 35,548 Decreased By -112 (-0.31%)
KSE100 114,256 Increased By 1049.3 (0.93%)
KSE30 35,870 Increased By 304.3 (0.86%)

NEW DELHI: India has resumed a small amount of exports of COVID-19 vaccines and will increase exports significantly in the next few months as domestic stocks build up and most of its own large population is inoculated, officials said on Wednesday.

One million shots of Covaxin produced by Indian company Bharat Biotech were shipped to Iran last week, the Indian embassy in Tehran said.

Vaccines have also been sent to Nepal, a government source said, adding that the effort is focused on neighbouring nations.

So far about 4 million shots have been exported, the source said, a small amount in proportion to the expansive vaccine diplomacy Prime Minister Narendra Modi's government launched this year before a second wave of infections forced a halt.

But now that three-quarters of the adult population have had one shot and a third have had both shots, India is poised to play an important role in meeting foreign nations' vaccine requirements, said V.K. Paul, who heads the government's task force on COVID-19.

"As India's needs are met, going forward there will be a generous stockpile of vaccines," Paul told reporters.

India considers resuming vaccine exports soon, focus on Africa, says source

The Serum Institute is producing 220 million shots of the Oxford AstraZeneca vaccine per month, up from 150 million in August, and Bharat Biotech is supplying 30 million shots of its home-grown vaccine which is set to rise to 50 million next month, he said.

With a few other locally developed vaccines moving closer to production or clearing regulatory approvals, India is expected to be producing 300-320 million shots a month by early next year -- more than the average 210 million doses it administers to its people each month, the officials said.

"A huge, huge availability of vaccines can be visualised for next year, we expect vaccines made in India to play a significant role in dealing with the pandemic across the world," Paul said.

India is the world's biggest maker of vaccines. Paul said it would in the next two or three days pass the 1 billion mark for vaccine doses administered since the start of its mass campaign to vaccinate all adult Indians.

Comments

Comments are closed.